Parkinson's Disease Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People who have been diagnosed with advanced Parkinson's disease that responds to a medication called levodopa
• People for whom a doctor has already independently decided to prescribe a specific under-the-skin (subcutaneous) medication called Foslevodopa/Foscarbidopa — this treatment decision must have been made before and separately from any invitation to join this study
• People for whom this under-the-skin medication has been prescribed in line with its approved guidelines and local health authority and funding rules

Who may not be able to join:

• People who have any medical condition listed as a reason not to use the under-the-skin Foslevodopa/Foscarbidopa medication, according to its officially approved product information
• People who are currently taking part in, or have taken part in, a clinical trial of an experimental drug within the past 30 days (note: taking part in an observational study or patient registry is generally acceptable — confirm with trial site)
• People who have a history of significant skin conditions or disorders (such as psoriasis or eczema), or who currently have temporary skin issues such as recent sunburn, acne, scarring, tattoos, open wounds, or skin discolouration, where the treating doctor considers these could interfere with the under-the-skin treatment or with study assessments

Important: Always verify eligibility with the trial site directly before applying.